Publication Name	World Journal of Gastroenterology
Manuscript ID	65896
Country	Italy

Received	2021-03-17 13:54
Peer-Review Started	2021-03-17 13:59
To Make the First Decision
Return for Revision	2021-04-16 01:34
Revised	2021-04-27 15:34
Second Decision	2021-08-30 03:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-30 09:15
Articles in Press	2021-08-30 09:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-13 00:44
Publish the Manuscript Online	2021-09-15 10:33

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Editorial
Article Title	Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis
Manuscript Source	Invited Manuscript
All Author List	Elena Genova, Gabriele Stocco and Giuliana Decorti
Funding Agency and Grant Number	Funding Agency Grant Number Italian Ministry of Health (IRCCS Burlo Garofolo) RC 7_2014
Corresponding Author	Giuliana Decorti, MD, Full Professor, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell'Istria 65, Trieste 34137, Italy. decorti@units.it
Key Words	nduced pluripotent stem cells; Therapy personalization; Patient-specific cells; Drug-induced pancreatitis; Thiopurines; Inflammatory bowel disease
Core Tip	About 5% of inflammatory bowel disease patients develop pancreatitis after thiopurine administration. The mechanism of this adverse effect is still not clear making it difficult to prevent. By differentiating induced pluripotent stem cells into their pancreatic exocrine counterpart, it is possible to set up innovative personalized in vitro models to study this adverse effect in a more effective way.
Publish Date	2021-09-15 10:33
Citation	Genova E, Stocco G, Decorti G. Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis. World J Gastroenterol 2021; 27(35): 5796-5802
URL	https://www.wjgnet.com/1007-9327/full/v27/i35/5796.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i35.5796

Full Article (PDF)	WJG-27-5796.pdf
Full Article (Word)	WJG-27-5796.docx
Manuscript File	65896_Auto_Edited-JLW.docx
Answering Reviewers	65896-Answering reviewers.pdf
Audio Core Tip	65896-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	65896-Conflict-of-interest statement.pdf
Copyright License Agreement	65896-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	65896-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	65896-Language certificate.pdf
Peer-review Report	65896-Peer-review(s).pdf
Scientific Misconduct Check	65896-Scientific misconduct check.pdf
Scientific Editor Work List	65896-Scientific editor work list.pdf
CrossCheck Report	65896-CrossCheck report.pdf